These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12932605)

  • 21. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
    Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
    Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.
    Ezekowitz JA; McAlister FA
    Eur Heart J; 2009 Feb; 30(4):469-77. PubMed ID: 19066207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function.
    Meune C; Wahbi K; Duboc D; Weber S
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):368-75. PubMed ID: 21193681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.
    Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N;
    Int J Cardiol; 2018 Dec; 272():260-266. PubMed ID: 30144995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.
    Khan MS; Fonarow GC; Ahmed A; Greene SJ; Vaduganathan M; Khan H; Marti C; Gheorghiade M; Butler J
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
    Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
    Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
    Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure.
    Kearney MT; Fox KA; Lee AJ; Prescott RJ; Shah AM; Batin PD; Baig W; Lindsay S; Callahan TS; Shell WE; Eckberg DL; Zaman AG; Williams S; Neilson JM; Nolan J
    J Am Coll Cardiol; 2002 Nov; 40(10):1801-8. PubMed ID: 12446064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical determinants and prognostic value of hemoglobin in hospitalized patients with systolic heart failure].
    Redondo-Bermejo B; Pascual-Figal DA; Hurtado-Martínez JA; Montserrat-Coll J; Peñafiel-Verdú P; Pastor-Pérez F; Giner-Caro JA; Valdés-Chávarri M
    Rev Esp Cardiol; 2007 Jun; 60(6):597-606. PubMed ID: 17580048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.
    Ahmed A; Husain A; Love TE; Gambassi G; Dell'Italia LJ; Francis GS; Gheorghiade M; Allman RM; Meleth S; Bourge RC
    Eur Heart J; 2006 Jun; 27(12):1431-9. PubMed ID: 16709595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction.
    Ersbøll M; Valeur N; Mogensen UM; Andersen MJ; Møller JE; Velazquez EJ; Hassager C; Søgaard P; Køber L
    J Am Coll Cardiol; 2013 Jun; 61(23):2365-73. PubMed ID: 23563128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD).
    Young JB; Weiner DH; Yusuf S; Pratt CM; Kostis JB; Weiss MB; Schroeder E; Guillote M
    South Med J; 1995 May; 88(5):514-23. PubMed ID: 7732439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-Year Mortality After Intensification of Outpatient Diuretic Therapy.
    Madelaire C; Gustafsson F; Stevenson LW; Kristensen SL; Køber L; Andersen J; D'Souza M; Biering-Sørensen T; Andersson C; Torp-Pedersen C; Gislason G; Schou M
    J Am Heart Assoc; 2020 Jul; 9(14):e016010. PubMed ID: 32662300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure.
    Ahmed A; Young JB; Love TE; Levesque R; Pitt B
    Int J Cardiol; 2008 Apr; 125(2):246-53. PubMed ID: 17706809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of renin-angiotensin-aldosterone system inhibitors on mortality, hospitalization, and diastolic function in patients with HFpEF. A meta-analysis of 13 randomized controlled trials.
    Zhang Q; Chen Y; Liu Q; Shan Q
    Herz; 2016 Feb; 41(1):76-86. PubMed ID: 26272273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.